Prognostic Utility of Serum Free Light Chain Ratios and Heavy-Light Chain Ratios in Multiple Myeloma in Three PETHEMA/GEM Phase III Clinical Trials
PLoS ONE - United States
doi 10.1371/journal.pone.0203392
Full Text
Open PDFAbstract
Available in full text
Categories
Date
September 7, 2018
Authors
Publisher
Public Library of Science (PLoS)